Skip to content

Drug interactions

Pexidartinib + Siponimod

Severity: Moderate

Pexidartinib and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pexidartinib is a CSF1R inhibitor with little immunosuppression, but it is hepatotoxic and is a CYP3A4 inducer, and siponimod is cleared by CYP2C9 and CYP3A4. Exposure to siponimod may fall and liver injury risk may overlap.

What this interaction means in plain words

Pexidartinib and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pexidartinib belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Pexidartinib may induce CYP3A4, lowering siponimod exposure, and both drugs can affect liver function.

What to do

Monitor liver tests and clinical response to siponimod. Consider alternatives if hepatic abnormalities arise.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pexidartinib and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Pexidartinib with Siponimod?

MediHelp rates the interaction as moderate. Pexidartinib and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pexidartinib is a CSF1R inhibitor with little immunosuppression, but it is hepatotoxic and is a CYP3A4 inducer, and siponimod is cleared by CYP2C9 and CYP3A4. Exposure to siponimod may fall and liver injury risk may overlap.

How serious is the interaction between Pexidartinib and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver tests and clinical response to siponimod. Consider alternatives if hepatic abnormalities arise.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in